Company Filing History:
4 out of 66 
2 out of 559 
1 out of 289 
Years Active: 2021-2025
Title: Inventor Spotlight: Melissa Works
Introduction
Melissa Works is an innovative inventor based in Seattle, WA, who has made significant contributions in the field of immunotherapy. With a total of three patents to her name, she is at the forefront of devising novel therapeutic approaches that aim to improve patient outcomes in cancer treatments.
Latest Patents
One of Melissa's most notable patents describes methods and combinations for treatment and T-cell modulation. This invention focuses on immunotherapies, particularly adoptive cell therapy, which includes T cell therapy enriched with immunomodulatory compounds such as thalidomide derivatives and inhibitors of E3-ubiquitin ligase. The methodologies outlined in this patent emphasize enhancing the efficacy, persistence, and proliferation of T cells, ultimately leading to improved therapy results.
Another key patent involves the combination of cell therapy with a gamma secretase inhibitor. This combination therapy aims to enhance the effects of T cell treatments in cancer patients. The patent details methods for engineering and preparing cells, as well as the development of kits and devices to assist in administering these innovative therapies.
Career Highlights
Throughout her career, Melissa has held prominent positions in reputed organizations such as Juno Therapeutics GmbH and Memorial Sloan Kettering Cancer Center. Her work at these institutions has contributed to advancements in the understanding and application of immunotherapeutic strategies.
Collaborations
Melissa has collaborated with esteemed colleagues including Blythe D. Sather and Eric L. Smith, furthering research and development in the cutting-edge area of cellular therapies. These partnerships have enabled the sharing of knowledge and resources, enhancing the impact of her work.
Conclusion
Melissa Works stands out as a prominent inventor in the realm of immunotherapy, with her innovative patents laying the groundwork for future advancements in the treatment of cancer. Through her collaborations and professional experiences, she continues to drive progress in the field, making a vital difference in patient care and therapeutic effectiveness.